Development of New Target-Based Anticancer Agents from Higher Plants
Development of New Target-Based Anticancer Agents from Higher Plants
批准号:
14572013
负责人:
MIKAMI Yoshihiro
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this research is to develop new target-based anticancer agents with apoptosis inducing activity from higher plants. The chemical constituents of Bulbinella floribunda (Liliaceae), Agave utahensis (Agavaceae), Tacca chantrieri (Taccaceae), Helleborus orientalis (Ranunculaceae), Helleborus niger (Ranunculaceae), Curculigo orchioides (Hypoxidaceae), and Tithonia diversifolia (Compositae) have been investigated. New phenylanthraquinone derivatives, new steroidal glycosides, cardeotonic glycosides, phytoecdysones, triterpenes with the cycloartane skeleton, and flavonoids and sesquiterpenoids were isolated from B.floribunda, A.utahensis, H.orientalis, H.niger, C.orchioides, and T.diversifolia, respectively, as cytotoxic and antitumor compounds, and their chemical structures were determined on the basis of the spectroscopic data and chemical evidence. Since the cytotoxic compounds isolated from the same plants are structurally related each other, the structure-activity relationships were established. In a panel-screening using a variety of cultured tumor cells, a phytoecdysone from H.niger, a cycloartane triterpene from C.orchioides, and a sesquiterpene from T.diversifolia showed differential cytotoxicity. Some 5β-spirostanol glycosides from A.utahensis caused the death of HL-60 cells through the apoptotic process.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/np030061l
发表时间:
2003-06
期刊:
Journal of natural products
影响因子:
5.1
作者:
[M. Kuroda;Y. Mimaki;H. Sakagami;Y. Sashida]
通讯作者:
M. Kuroda;Y. Mimaki;H. Sakagami;Y. Sashida
Kazuki Watanabe, Yoshihiro Mimaki, Hiroshi Sakagami, Yutaka Sashida: "Bufadienolide and Spirostanol Glycosides from the Rhizomes of Helleborus orientalis"Journal of Natural Products. 66・2. 236-241 (2003)
Kazuki Watanabe、Yoshihiro Mimaki、Hiroshi Sakagami、Yutaka Sashida:“来自东方铁卢根茎的 Bufadienolide 和螺甾烷醇糖苷”Journal of Natural Products 66・2。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.3987/com-04-10319
发表时间:
2005-04
期刊:
Heterocycles
影响因子:
0.6
作者:
[Kazuki Watanabe;H. Sakagami;Y. Mimaki]
通讯作者:
Kazuki Watanabe;H. Sakagami;Y. Mimaki
Functional Polyphenols and Carotenes with Antioxidative Action
具有抗氧化作用的功能性多酚和胡萝卜素
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[Kadoma Y., Fujisawa S., Ishihara M., Fujisawa S., Fujisawa S., Inoue K., Ishihara M., Momoi K., Sakagami H., MARIKO ISHIHARA, SEIICHIRO FUJISAWA, SEIICHIRO FUJISAWA, SEIICHIRO FUJISAWA, SEIICHIRO FUJISAWA, SEIICHIRO FUJISAWA, Sakagami H.]
通讯作者:
Sakagami H.
DOI:
10.1021/np020094l
发表时间:
2002-09-01
期刊:
JOURNAL OF NATURAL PRODUCTS
影响因子:
5.1
作者:
[Yokosuka, A, Mimaki, Y, Sashida, Y]
通讯作者:
Sashida, Y
共 11 条
Development of New Anticancer Agents with New Pharmacological Mechanism
-
批准号:11672118
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1999
-
负责人:MIKAMI Yoshihiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: